Home

haie Conformité à Quatre markers for identification of resectable pancreatic cancer patients Suis prêt Mentalité Germer

Locally Advanced Pancreatic Cancer | MDedge Hematology and Oncology
Locally Advanced Pancreatic Cancer | MDedge Hematology and Oncology

Circulating stromal cells in resectable pancreatic cancer correlates to  pathological stage and predicts for poor clinical outcomes | npj Precision  Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology

Trends in Neoadjuvant Approaches in Pancreatic Cancer in: Journal of the  National Comprehensive Cancer Network Volume 15 Issue 8 (2017)
Trends in Neoadjuvant Approaches in Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 8 (2017)

Identification and prognostic analysis of biomarkers to predict the  progression of pancreatic cancer patients | Molecular Medicine | Full Text
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text

Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic  Cancer | Journal of Nuclear Medicine
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer | Journal of Nuclear Medicine

Identification of candidate diagnostic and prognostic biomarkers for  pancreatic carcinoma - eBioMedicine
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine

Clinicodemographic aspect of resectable pancreatic cancer and prognostic  factors for resectable cancer | World Journal of Surgical Oncology | Full  Text
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer | World Journal of Surgical Oncology | Full Text

Circulating stromal cells in resectable pancreatic cancer correlates to  pathological stage and predicts for poor clinical outcomes | npj Precision  Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology

Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic  Cancer In Vivo | Journal of Proteome Research
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research

Markers of pancreatic cancer stem cells and their clinical and therapeutic  implications | SpringerLink
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink

Markers of pancreatic cancer stem cells and their clinical and therapeutic  implications | SpringerLink
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink

Consensus guidelines for diagnosis, treatment and follow-up of patients  with pancreatic cancer in Spain | SpringerLink
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain | SpringerLink

Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic  Cancer In Vivo | Journal of Proteome Research
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research

Circulating stromal cells in resectable pancreatic cancer correlates to  pathological stage and predicts for poor clinical outcomes | npj Precision  Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology

Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable  Pancreatic Cancer
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer

Treatment for potentially resectable exocrine pancreatic cancer - UpToDate
Treatment for potentially resectable exocrine pancreatic cancer - UpToDate

Identification and prognostic analysis of biomarkers to predict the  progression of pancreatic cancer patients | Molecular Medicine | Full Text
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis,  treatment and follow-up† - Annals of Oncology
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology

Identification and prognostic analysis of biomarkers to predict the  progression of pancreatic cancer patients | Molecular Medicine | Full Text
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text

Pancreatic Cancer CT: Prediction of Resectability according to NCCN  Criteria | Radiology
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology

Pancreas: Pancreatic Adenocarcinoma Imaging Pearls - Educational Tools | CT  Scanning | CT Imaging | CT Scan Protocols - CTisus
Pancreas: Pancreatic Adenocarcinoma Imaging Pearls - Educational Tools | CT Scanning | CT Imaging | CT Scan Protocols - CTisus

Moving the Bar in Pancreatic Cancer
Moving the Bar in Pancreatic Cancer

Resectable and Borderline Resectable Pancreatic Cancer | SpringerLink
Resectable and Borderline Resectable Pancreatic Cancer | SpringerLink